Aller au contenu

← Journal/13 July 2026·3 min de lecture

The biphasic effect of CBD: why the dose changes everything

Par ·

CBD shows what is known as a biphasic dose-response effect: an intermediate dose can produce a more marked effect than a low dose or, conversely, than a high dose (source: Linares et al., Braz. J. Psychiatry, 2019). In that trial, an intermediate dose reduced participants' anxiety, whereas lower or higher doses proved less effective (source: Linares et al., 2019).

The biphasic effect of CBD: why the dose changes everything

What is a biphasic effect?

A biphasic effect describes a response that does not follow a simple "the more I take, the stronger the effect" relationship. It traces instead an inverted U-shaped curve: the effect increases with the dose up to a certain point, then declines beyond it (source: Linares et al., 2019).

This type of response is not specific to CBD; it is observed with many active substances. What sets CBD apart is that this curve has been documented specifically in an anxiety context, with doses compared directly within a single trial.

What exactly does the study by Linares and colleagues show?

Published in 2019 in the Brazilian Journal of Psychiatry, this study compared several doses of CBD in participants placed in a stress-inducing situation (source: Linares et al., 2019). An intermediate dose reduced anxiety more markedly than the lowest doses and the highest doses tested.

This finding often surprises new users, who are used to the idea that increasing a dose systematically strengthens its effect. On the contrary, it illustrates the complexity of CBD pharmacology, whose action varies with the quantity consumed and the physiological context.

Why favour a gradual approach?

This biphasic phenomenon supports the widely recommended approach of "start low, go slow" (source: pharmacological reviews). Rather than aiming straight for a high dose in the hope of a stronger effect, it is preferable to adjust your intake in steps, observing your own response.

This logic aligns with the dosing markers set out by health authorities, including the provisional safety dose recently published by the EFSA (see our article on how much CBD to take per day according to the EFSA). Finding your personal dose takes time and consistency, not a rapid escalation.

Does this biphasic effect apply to all uses of CBD?

The available data mainly concern one specific context, the experimental anxiety studied by Linares and colleagues. It would be excessive to extrapolate this result to every possible use of CBD without qualification.

What can be taken away, however, is that the relationship between dose and effect is not linear for CBD. That is a further argument for adjusting your intake gradually, particularly during the first sublingual doses, a method detailed in our article on taking CBD under the tongue.

Frequently asked questions

What is a biphasic dose-response effect?

It is a curved response, in which an intermediate dose produces a more marked effect than a low or a high dose (source: Linares et al., 2019). This phenomenon has been observed for CBD in an anxiety context.

Is a higher dose of CBD always more effective?

No, the study by Linares and colleagues shows the opposite: doses that are too high can be less effective than an intermediate dose (source: Linares et al., 2019). That is one reason to avoid rapid increases.

How do you find your personal CBD dose?

The recommended approach is to start with a low dose and increase it gradually, observing the effects felt (source: pharmacological reviews). Every body reacts differently.

Does this effect hold for all cannabinoids?

The data cited concern CBD specifically, in a context of experimental anxiety. Other cannabinoids do not necessarily have the same documented dose-response profile to date.


Written by the Phytogrammes team

Every article in this journal draws on primary sources (ANSM, EFSA, EUR-Lex, peer-reviewed publications) and on the lab's own practice: batch-by-batch HPLC analyses, measured cannabinoid profiles. Our approach.

Article published on . CBD is not a medicine.

Phytogrammes products that pair well